Purpose: The purpose of this guideline is to provide a useful reference on the effective
evidence-based diagnoses and management of non-metastatic upper tract urothelial …

Methods A non-systematic review of the literature was conducted by performing an
electronic literature search using PubMed with “radical nephroureterectomy” and “oncologic …

The types of urothelial carcinoma (UC) include urothelial bladder cancer and upper tract
urothelial carcinoma. Current diagnostic techniques cannot meet the needs of patients …

Simple Summary To choose the appropriate treatment for patients with upper tract urothelial
carcinoma (UTUC), proper diagnosis and risk assessment of the disease is mandatory. This …

Upper tract urothelial carcinoma (UTUC) is a rare malignancy, occurring in 5–10% of
patients diagnosed with UC, and involves the renal pelvis, calyces, or ureters. UTUC can be …

This article is an English translation of the Clinical Practice Guidelines for Upper Tract
Urothelial Carcinoma (2nd edition) published in June 2023. The Japanese Urological …

Context Bladder recurrences have been reported in 22–47% of patients after surgery for
upper urinary tract urothelial carcinoma (UTUC). This collaborative review focuses on risk …

Simple Summary The standard of care for patients diagnosed with upper tract urothelial
carcinoma (UTUC) is surgery. However, the current standard tools for the diagnosis and …

Current guidelines recommend endoscopic management (EM) for patients with low‐risk
upper urinary tract urothelial carcinoma, as well as those with an imperative indication …

Background UGN-101 is a novel delivery system for intracavitary treatment of upper tract
urothelial cancer (UTUC). UGN-101 was approved based on a pivotal trial for small volume …